Literature DB >> 6768286

Hyaline membrane disease. A controlled study of inspiratory to expiratory ratio in its management by ventilator.

R C Spahr, A M Klein, D R Brown, H M MacDonald, I R Holzman.   

Abstract

Sixty-nine neonates with severe hyaline membrane disease (HMD) were mechanically ventilated using either a 1:2 or a 2:1 inspiratory to expiratory (I/E) ratio. Survivors in the 2:1 group required a lower fraction of oxygen in the inspired air (FiO2) and lower end-expiratory pressure to achieve satisfactory oxygenation. During the first week of life, time of exposure to FiO2 greater than 0.60 while being mechanically ventilated was 29.7 +/- 7.5 hours for the 1:2 group and 6.6 +/- 2,7 hours for the 2:1 group, while time of exposure to end-expiratory pressure greater than 3 cm H2O was 49.4 +/- 7.9 hours for the 1:2 group and 13.4 +/- 7.4 hours for the 2:1 group. Mortality and the incidence of air leak, patent ductus arteriosus, intraventricular hemorrhage, necrotizing enterocolitis, bronchopulmonary dysplasia, and pulmonary hemorrhage were not different for the two groups. Using an increased I/E ratio during the acute phase of HMD improved oxygenation but did not alter morbidity or mortality.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6768286     DOI: 10.1001/archpedi.1980.04490010031011

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  4 in total

1.  Ventilator settings for newborn infants.

Authors:  C A Ramsden; E O Reynolds
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

2.  High and conventional rates of positive pressure ventilation.

Authors:  D Field; A D Milner; I E Hopkin
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

3.  Time-cycled inverse ratio ventilation does not improve gas exchange during anaesthesia.

Authors:  W A Tweed; T L Lee
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

Review 4.  Long versus short inspiratory times in neonates receiving mechanical ventilation.

Authors:  C O F Kamlin; P G Davis
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.